Reduction of mefenamic acid of increased menstrual blood loss associated with intrauterine contraception.
D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007434:Intrauterine Devices / Q000009:adverse effects*; D008528:Mefenamic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D008599:Menstruation Disturbances / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors
D008528:Mefenamic Acid